Does TNFi Therapy for Psoriatic Arthritis Affect COVID-19 Vaccine Immunogenicity?
Researchers studied the immune response to COVID-19 vaccination in patients with psoriatic arthritis receiving treatment with tumor necrosis factor inhibitors.
Researchers studied the immune response to COVID-19 vaccination in patients with psoriatic arthritis receiving treatment with tumor necrosis factor inhibitors.
At an ACR Convergence 2021 session, John Aucott, MD, and Sheila Arvikar, MD, discussed the various aspects of Lyme arthritis, including incidence, prevalence, symptoms, and treatments, and other tick-borne illnesses, to inform rheumatologists in practice.
The European Alliance of Associations for Rheumatology (EULAR) has issued points-to-consider for conducting clinical trials and observational studies among individuals at risk for rheumatoid arthritis.
The AHA has issued a Presidential Advisory Statement outlining considerations for addressing the effects of opioids on cardiovascular and neurovascular health.
The task force established by the EULAR developed evidence-based recommendations for intra-articular therapies in adult patients with peripheral arthropathies.